Studies of Neurological Paraneoplastic Syndromes
NCT00587106 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51
Last updated 2009-03-30
Summary
This study is for patients with cancer, a known paraneoplastic syndrome, or neurological problems that suggest a paraneoplastic syndrome.
Conditions
- Paraneoplastic Neurologic Degenerations (PNDs)
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Jerome Posner, MD · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1988-04-30
- Primary Completion
- 2009-03-31
- Completion
- 2009-03-31
Countries
- United States
Study Locations
More Related Trials
-
Molecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine Tumors
NCT02092714 ·Status: UNKNOWN
-
Prediction of True Oligo-metastatic Disease.
NCT05806151 ·Status: RECRUITING
-
Molecular and Genomic Profiling of Head and Neck Tumors
NCT00200486 ·Status: RECRUITING
-
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
NCT05588154 ·Status: RECRUITING
-
Detection of CSF Next Generation Sequencing in the Application of Brain Metastases From Lung Adenocarcinoma or Meningeal Metastasis
NCT03029065 ·Status: UNKNOWN
-
Study of Specimens From Young Patients With Neuroblastoma
NCT00958659 ·Status: COMPLETED
-
S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma
NCT00985699 ·Status: COMPLETED
-
Genetic Analysis of Brain Tumors
NCT00031538 ·Status: TERMINATED
-
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
NCT02269592 ·Status: RECRUITING
-
CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases
NCT02058953 ·Status: COMPLETED
-
Studying Gene Expression and Location in Samples From Patients With Brain Tumors
NCT01585389 ·Status: COMPLETED
-
Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma
NCT00588198 ·Status: COMPLETED
-
Longitudinal Study of Biomarkers
NCT01595126 ·Status: COMPLETED
-
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
NCT00230308 ·Status: RECRUITING
-
Genomic Predictors of Papillary Microcarcinoma Disease Progression
NCT02363595 ·Status: RECRUITING
-
Prediction of Getting Peripheral Neuropathy in Patients Treated With Bortezomib?
NCT05781425 ·Status: COMPLETED
-
Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery
NCT03071913 ·Status: COMPLETED
-
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
NCT02958462 ·Status: RECRUITING ·Phase: NA
-
Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer
NCT00826579 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
NCT01919749 ·Status: COMPLETED ·Phase: NA
-
Collection of Tissue Blocks or Slides From Patients With Cancer
NCT02810405 ·Status: COMPLETED
-
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
NCT02090530 ·Status: RECRUITING
-
Newer Therapeutic Targets in Head and Neck Cancers
NCT05382585 ·Status: RECRUITING
-
Predictors of Node Positivity in Endometrial Cancer
NCT05793333 ·Status: RECRUITING
-
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
NCT02610439 ·Status: RECRUITING